Learning objectives:
- Historically, what has been lacking in clinical trials when it comes to diversity and inclusion
- Why it took federal guidelines to begin to turn the conversation toward pharma and health equity
- How big data can fuel trial diversity and why the data matters as well as a case study
- What the ABC(and D’s) are of clinical trial diversity, equity, access, and inclusion and diversity
- Why geography and patient representation matter
